Status message

Requested page could not be found.
Read time: 0 mins
Warning on the risks of hair straightening products containing glyoxylic acid
lissage

Warning on the risks of hair straightening products containing glyoxylic acid

Our news

Understanding the impact of pathogenic bacteria in the intestinal microbiota of pigs and chickens on human health
un élevage de poules
29/10/2024

Understanding the impact of pathogenic bacteria in the intestinal microbiota of pigs and chickens on human health

The presence of certain bacteria or chemicals can modulate the intestinal microbiota of pigs and chickens. Studying these factors could help at the farm level to tackle micro-organisms that are pathogenic to humans, such as Campylobacter and Salmonella .
Which work processes involve a risk of occupational cancer?
24/10/2024

Which work processes involve a risk of occupational cancer?

Certain work processes, including activities or working conditions, can cause cancer. How can their carcinogenicity be identified in order to better protect exposed workers? ANSES has developed a method for identifying carcinogenic processes, and used it to assess the carcinogenicity of three of them. It also drew up a priority list of processes needing expert appraisal over the coming years.
Two calls for research proposals to gain a better understanding of environmental and occupational health risks
Actualité APR PNR EST
14/10/2024
News

Two calls for research proposals to gain a better understanding of environmental and occupational health risks

Under the National Research Programme for Environmental and Occupational Health (PNR EST), ANSES is launching two calls for research proposals. The aim is to gain a better understanding of issues that are still relatively unexplored, but which are considered to be of major importance to human health and ecosystems.
A draft expert appraisal report on "Radiofrequencies and cancer" submitted for public consultation
Radiofréquences
30/09/2024

A draft expert appraisal report on "Radiofrequencies and cancer" submitted for public consultation

Since ANSES's last general expert appraisal on the health effects of exposure to radiofrequencies in 2013, new data have been published in numerous scientific studies. The Agency therefore undertook a revision of its expert appraisal on the carcinogenic risk from exposure to radiofrequency electromagnetic fields. To do this, it applied an international reference method for assessing the weight of evidence to the new data. It is now submitting the corresponding draft expert appraisal report for public consultation, in order to collect any scientific comments that need to be taken into account when drafting the final version of the report. This public consultation began on 30 September 2024. The deadline, initially scheduled for 30 October, has been extended to 25 November 2024.

Focus on

Five questions on bluetongue

Five questions on bluetongue

Bluetongue is a viral disease of ruminants, and does not affect humans or food. It is transmitted by biting midges and can cause major economic losses in livestock farming. Vaccination is the most...
Endocrine disruptors, a scientific challenge

Endocrine disruptors, a scientific challenge

Endocrine disruptors are substances that can interfere with our hormonal system and cause adverse effects. Given the multiple sources of exposure, scientists need to understand the role played by...
PFASs: very persistent chemicals

PFASs: very persistent chemicals

Per- and polyfluoroalkyl substances, better known as PFASs, are chemicals whose specific properties mean that they are used in many everyday products. Extremely persistent, PFASs are found in all...
Antimicrobial resistance in animal health: a One Health approach
Antibiorésistance en santé animale et dans l’environnement
19/11/2024

Antimicrobial resistance in animal health: a One Health approach

Matinée
Public :
En ligne
Antibiotic-resistant bacteria represent a major health problem in France and beyond. ANSES works alongside other organisations to ensure that antibiotics remain effective. More specifically, we are responsible for monitoring their use in veterinary medicine, as well as the emergence and spread of resistance in bacteria found in livestock, food and the environment.

Portals

Our Laboratories
femmes

Our Laboratories

Veterinary medicinal products
Médicaments vétérinaires

Veterinary medicinal products

Agency news

01/07/2024
Inside ANSES
Occupational health

ANSES and the ANSM strengthen their partnership

On 12 June, ANSES and the ANSM signed a new framework agreement to reinforce their partnership across the entire field of human and veterinary medicinal products. This new agreement between the two health agencies also provides for cooperation to be extended to all possible synergies according to the "One Health" approach.
05/06/2024
Veterinary medicine - ANMV

The French Agency for Veterinary Medicinal Products celebrates its 30th anniversary

The French Agency for Veterinary Medicinal Products (ANMV) was created in 1994. Part of ANSES, it monitors the efficacy of the veterinary medicinal products used in France and ensures they are environmentally friendly and safe for animal and human health. The ANMV’s missions and importance on the French and European scenes have changed significantly over the past 30 years. Below, Franck Fourès, Director of the ANMV, looks back at its history and discusses the major challenges that lie ahead.
24/05/2024
Inside ANSES
Environmental health

ANSES and Institut Pasteur: a partnership at the service of One Health

Institut Pasteur and ANSES have just signed a partnership agreement to pool their skills in the interests of ‘One Health’. The two organisations carry out complementary activities: one studies human infectious diseases and the other the risks associated with animal diseases and food, including diseases transmitted from animals to humans and by vectors.
27/03/2024
Inside ANSES
Environmental health

The fundamental principles underlying ANSES’s vigilance schemes

ANSES coordinates seven vigilance schemes aimed at identifying adverse effects caused by several types of products and foods. What are the fundamental principles underpinning this mission at the Agency? What do the new vigilance schemes for cosmetics and tattoos involve? What is the outlook for these schemes? Juliette Bloch, Director of Health Alerts and Vigilance, answers our questions.